Diabetes Clinical Trials in Atlanta

Showing 581-600 of 621 trials

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

NCT00928057

Anxiety about needles is a commonly expressed concern by diabetics about beginning insulin therapy. A shorter, thinner pen needle that delivers insulin with the safety and efficacy profile of currently marketed pen needles may appeal to many diabetic patients as the new needle may be perceived as less intimidating and more comfortable. Currently marketed pen needles range in length from 5 to 12.7 millimeters (mm). The primary purpose of this study was to evaluate whether the investigational 4mm x 32 Gauge(G) pen needle manufactured by Becton, Dickinson and Company (BD) provides equivalent glucose control (as measured by fructosamine levels) as the currently marketed BD 5mm x 31 G and BD 8mm x 31 G pen needles (PN)in diabetic subjects with varying insulin dosage regimens.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Becton, Dickinson and Company173 participantsStarted Jun 2009

Birmingham, Alabama, United States • Escondido, California, United States • Atlanta, Georgia, United States +1 more locations

COMPLETEDPhase 2/3< 1 mile

Dose Ranging Study With LT, Monotherapy, PPAR

NCT00240383

A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes

Diabetes Mellitus II

Bristol-Myers Squibb1,260 participantsStarted May 2002

Anniston, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +269 more locations

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Dose Ranging Study With LT, Monotherapy, PPAR

Diabetes Trials in Other Cities

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

PPAR-COMBO With Sulfonylurea

Remote Monitoring in Diabetes Disease Management

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Diabetes Control and Complications Trial (DCCT)

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

GALLANT 6 Tesaglitazar vs. Pioglitazone

A Study for Type 2 Diabetic Patients

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Other Conditions in Atlanta